Poultry Vaccines Market Research Report – Global Forecast till 2023

Poultry Vaccines Market Size, Growth And Trends Analysis By Diseases (Infectious Bronchitis, Marek's Disease), Technology (Toxoid, Recombinant, Inactivated, Live Attenuated Vaccines (Lav)), Dosage Form (Duct, Liquid, Freeze Dried Vaccines) — Global Forecast Till 2023

ID: MRFR/HC/6046-HCR | February 2021 | Region: Global | 85 pages

Market Scenario


The global poultry vaccines market is accounted for USD 13,35.81 million in 2017 and expected to register ~ 7.25% CAGR during the forecast period (2018–2023).


Vaccination plays vital role in managing the health of poultry flock. There are many diseases that are prevented or reduced by vaccinating the poultry flock. vaccine helps to boost the bird’s immune system that produce antibodies, that allow birds body to fight again invading causal organisms.


The rising prevalence of animal diseases, increasing awareness about animal vaccination, growth in poultry population and outbreaks of poultry diseases, technological advancements, and improvement in government initiatives are boosting market growth. Moreover, rising demand for animal protein, improvement in productivity, and rising focus toward food safety are contributing boosting the growth of the market. For instance, in November 2018, MSD & Co. Inc. launched the INNOVAX-ND-IBD, the companies first live poultry vaccine in the US market.


The high cost associated with poultry vaccines, lack of awareness regarding poultry vaccines, and unaffordability of veterinary services in underdeveloped and developing regions may hamper the growth of the market during the assessment period. For instance, according to the National Institute of Standards and Technology (NIST), in January 2016, more than 35.0% of vaccines lost their potency during the global shipping, as they were stored at temperatures that were either too high or too low.


Segmentation


The global poultry vaccines market has been segmented on the basis of diseases, technology, dosage form and region.


On the basis of disease, the market has been classified as infectious bronchitis, avian influenza, marek's disease, newcastle disease, and others. the market, by technology, has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines (lav), and others. based on dosage form, the market has been segmented into duct vaccines, liquid vaccines, and freeze-dried vaccines.


The live attenuated vaccines segment is expected to hold the largest market share of the poultry vaccines market, by technology, during the forecast period. Also, recombinant vaccines segment to register the highest CAGR in the global poultry vaccines market during the forecast period.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The poultry vaccines market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European poultry vaccines market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The poultry vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The poultry vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Poultry Vaccines Market Share, by Region, 2017 (%)


Poultry Vaccines Market


Source: MRFR Analysis


The Americas are likely to dominate the global poultry vaccines market owing to the awareness about the prevention of animal-to-human transmission diseases, safe animal food supply, and rising investment in research and development for animal vaccines. Moreover, high expenditure spending on healthcare and the presence of veterinary hospitals coupled with favorable reimbursement rates in the US and Canada also fueling the growth of the market during forecast periods. For instants, according to the American Veterinary Medical Association, in 2018, around 6.9% of spending increased on veterinary care.


The European market is expected to be the second-largest poultry vaccines market. The market growth in this region can be attributed to the government support for research & development, increasing production of veterinary products, and improved animal husbandry practices.


Asia-Pacific is expected to be the fastest-growing poultry vaccines market during the forecast period owing to penetration of the veterinary sector, a surging number of private veterinary clinics, and increasing awareness about animal welfare in China, India, and Australia.


The market in the Middle East & Africa is expected to account for the smallest share of the global poultry vaccines market due to lack of skilled veterinarians, high cost of treatment, and poor medical facilities.


Key Players


Some of the key players in the global poultry vaccines market are Boehringer Ingelheim, Elanco, MSD & Co., Zoetis Inc, Ceva Animal Health Inc., Phibro Animal Health Corporation, Virbac, Hipra, Venkys, Biovet, and Anicon GmbH, and Others.


Global Poultry vaccines Market, by Diseases



  • Infectious bronchitis

  • Avian Influenza

  • Marek's Disease

  • Newcastle Disease

  • Others


Global Poultry vaccines Market, by Technology



  • Toxoid Vaccines

  • Recombinant Vaccines

  • Inactivated Vaccines

  • Live Attenuated Vaccines (LAV)

  • Others


Global Poultry vaccines Market, by Dosage Form



  • Duct Vaccines

  • Liquid Vaccines

  • Freeze Dried Vaccines


Global Poultry vaccines Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles    



  • Boehringer Ingelheim

  • Elanco

  • MSD & Co.

  • Zoetis Inc

  • Ceva Animal Health Inc.

  • Phibro Animal Health Corporation

  • Virbac

  • Hipra

  • Venkys

  • Biovet

  • Anicon GmbH

  • Others


Intended Audience



  • Veterinary vaccine products manufacturers and vendors

  • Research organization

  • Various research and consulting firms

  • Veterinary hospital

  • Animal health organization and association



Table of Contents:


Chapter 1. Report Prologue


Chapter 2. Market Introduction


2.1. Definition


2.2. Scope of the Study


2.2.1. Research Objective


2.2.2. Assumptions


2.2.3. Limitations


Chapter 3. Research Methodology


3.1. Introduction


3.2. Primary Research


3.3. Secondary Research


3.4. Market Size Estimation


Chapter 4. Market Dynamics


4.1. Drivers


4.2. Restraints


4.3. Opportunities


4.4. Challenges


4.5. Macroeconomic Indicators


Chapter 5. Market Factor Analysis


5.1. Porter’s Five Forces Analysis


5.1.1. Bargaining Power of Suppliers


5.1.2. Bargaining Power of Buyers


5.1.3. Threat of New Entrants


5.1.4. Threat of Substitutes


5.1.5. Intensity of Rivalry


5.2. Value Chain Analysis


5.3. Investment Feasibility Analysis


5.4. Pricing Analysis


Chapter 6. Global Poultry Vaccines Market, by Diseases


6.1. Introduction


6.2. Infectious bronchitis


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.3. Avian Influenza


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.4. Marek's Disease


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.5. Newcastle Disease


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.6. Others


Chapter 7. Global Poultry Vaccines Market, by Technology


7.1. Introduction


7.2. Toxoid Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.3. Recombinant Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.4. Inactivated Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.5. Live Attenuated Vaccines (LAV)


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.6. Others


Chapter 8. Global Poultry Vaccines Market, by Dosage Form


8.1. Introduction


8.2. Duct Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


8.3. Liquid Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


8.4. Freeze Dried Vaccines


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


8.5. Others


Chapter 9. Global Poultry Vaccines Market, by Region


9.1. Introduction


9.2. Americas


9.2.1. North America


9.2.1.1. US


9.2.1.2. Canada


9.2.2. Latin America


9.3. Europe


9.3.1. Western Europe


9.3.1.1. Germany


9.3.1.2. France


9.3.1.3. Italy


9.3.1.4. Spain


9.3.1.5. UK


9.3.1.6. Rest of Western Europe


9.3.2. Eastern Europe


9.4. Asia-Pacific


9.4.1. Japan


9.4.2. China


9.4.3. India


9.4.4. Australia


9.4.5. South Korea


9.4.6. Rest of Asia-Pacific


9.5. Middle East & Africa


9.5.1. Middle East


9.5.2. Africa


Chapter 10. Company Landscape


10.1. Introduction


10.2. Market Share Analysis


10.3. Key Developments & Strategies


Chapter 11. Company Profiles


11.1. Boehringer Ingelheim GmbH


11.1.1. Company Overview


11.1.2. Product Overview


11.1.3. Financials Overview


11.1.4. Key Developments


11.1.5. SWOT Analysis


11.1.6. Key Strategies


11.2. Elanco


11.2.1. Company Overview


11.2.2. Product Overview


11.2.3. Financials Overview


11.2.4. Key Developments


11.2.5. SWOT Analysis


11.2.6. Key Strategies


11.3. MSD & Co.


11.3.1. Company Overview


11.3.2. Product Overview


11.3.3. Financials Overview


11.3.4. Key Developments


11.3.5. SWOT Analysis


11.3.6. Key Strategies


11.4. Zoetis Inc


11.4.1. Company Overview


11.4.2. Product Overview


11.4.3. Financials Overview


11.4.4. Key Developments


11.4.5. SWOT Analysis


11.4.6. Key Strategies


11.5. Ceva Animal Health Inc.


11.5.1. Company Overview


11.5.2. Product Overview


11.5.3. Financials Overview


11.5.4. Key Developments


11.5.5. SWOT Analysis


11.5.6. Key Strategies


11.6. Phibro Animal Health Corporation


11.6.1. Company Overview


11.6.2. Product Overview


11.6.3. Financials Overview


11.6.4. Key Developments


11.6.5. SWOT Analysis


11.6.6. Key Strategies


11.7. Virbac


11.7.1. Company Overview


11.7.2. Product Overview


11.7.3. Financials Overview


11.7.4. Key Developments


11.7.5. SWOT Analysis


11.7.6. Key Strategies


11.8. Hipra


11.8.1. Company Overview


11.8.2. Product Overview


11.8.3. Financials Overview


11.8.4. Key Developments


11.8.5. SWOT Analysis


11.8.6. Key Strategies


11.9. Venkys


11.9.1. Company Overview


11.9.2. Product Overview


11.9.3. Financials Overview


11.9.4. Key Developments


11.9.5. SWOT Analysis


11.9.6. Key Strategies


11.10. Biovet


11.10.1. Company Overview


11.10.2. Product Overview


11.10.3. Financials Overview


11.10.4. Key Developments


11.10.5. SWOT Analysis


11.10.6. Key Strategies


11.11. Anicon GmbH


11.11.1. Company Overview


11.11.2. Product Overview


11.11.3. Financials Overview


11.11.4. Key Developments


11.11.5. SWOT Analysis


11.11.6. Key Strategies


11.12. Others


Chapter 12. MRFR Conclusion


12.1. Key Findings


12.1.1. From CEO’s View point


12.1.2. Unmet Needs of the Market


12.2. Key Companies to Watch


12.3. Predictions for the Poultry Vaccines Industry


Chapter 13. Appendix




LIST OF TABLES


Table 1. Global Poultry Vaccines Market Synopsis, 2018–2023


Table 2. Global Poultry Vaccines Market Estimates and Forecast, 2018–2023 (USD Million)


Table 3. Global Poultry Vaccines Market, by Region, 2018–2023 (USD Million)


Table 4. Global Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 5. Global Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 6. Global Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 7. North America: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 8. North America: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 9. North America: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 10. US: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 11. US: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 12. US: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 13. Canada: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 14. Canada: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 15. Canada: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 16. Latin America: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 17. Latin America: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 18. Latin America: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 19. Europe: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 20. Europe: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 21. Europe: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 22. Western Europe: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 23. Western Europe: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 24. Western Europe: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 25. Eastern Europe: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 26. Eastern Europe: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 27. Eastern Europe: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 28. Asia-Pacific: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 29. Asia-Pacific: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 30. Asia-Pacific: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


Table 31. Middle East & Africa: Poultry Vaccines Market, by Diseases, 2018–2023 (USD Million)


Table 32. Middle East & Africa: Poultry Vaccines Market, by Technology, 2018–2023 (USD Million)


Table 33. Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2018–2023 (USD Million)


LIST OF FIGURES


Figure 1. Research Process


Figure 2. Segmentation for Global Poultry Vaccines Market


Figure 3. Segmentation Market Dynamics for Global Poultry Vaccines Market


Figure 4. Global Poultry Vaccines Market Share, by Diseases, 2017


Figure 5. Global Poultry Vaccines Market Share, by Technology, 2017


Figure 6. Global Poultry Vaccines Market Share, by Dosage Form, 2017


Figure 7. Global Poultry Vaccines Market Share, by Region, 2017


Figure 8. North America: Poultry Vaccines Market Share, by Country, 2017


Figure 9. Europe: Poultry Vaccines Market Share, by Country, 2017


Figure 10. Asia-Pacific: Poultry Vaccines Market Share, by Country, 2017


Figure 11. Middle East & Africa: Poultry Vaccines Market Share, by Country, 2017


Figure 12. Global Poultry Vaccines Market: Company Share Analysis, 2017 (%)


Figure 13. Boehringer Ingelheim GmbH: Key Financials


Figure 14. Boehringer Ingelheim GmbH: Segmental Revenue


Figure 15. Boehringer Ingelheim GmbH: Geographical Revenue


Figure 16. Elanco: Key Financials


Figure 17. Elanco: Segmental Revenue


Figure 18. Elanco: Geographical Revenue


Figure 19. MSD & Co.: Key Financials


Figure 20. MSD & Co.: Segmental Revenue


Figure 21. MSD & Co.: Geographical Revenue


Figure 22. Zoetis: Key Financials


Figure 23. Zoetis: Segmental Revenue


Figure 24. Zoetis: Geographical Revenue


Figure 25. Ceva Animal Health Inc.: Key Financials


Figure 26. Ceva Animal Health Inc.: Segmental Revenue


Figure 27. Ceva Animal Health Inc.: Geographical Revenue


Figure 28. Phibro Animal Health Corporation: Key Financials


Figure 29. Phibro Animal Health Corporation: Segmental Revenue


Figure 30. Phibro Animal Health Corporation: Geographical Revenue


Figure 31. Virbac: Key Financials


Figure 32. Virbac: Segmental Revenue


Figure 33. Virbac: Geographical Revenue


Figure 34. Hipra: Key Financials


Figure 35. Hipra: Segmental Revenue


Figure 36. Hipra: Geographical Revenue


Figure 37. Venkys: Key Financials


Figure 38. Venkys: Segmental Revenue


Figure 39. Venkys: Geographical Revenue


Figure 40. Biovet: Key Financials


Figure 41. Biovet: Segmental Revenue


Figure 42. Biovet: Geographical Revenue


Figure 43. Anicon GmbH: Key Financials


Figure 44. Anicon GmbH: Segmental Revenue


Figure 45. Anicon GmbH: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.